NovoCure (NVCR) Gross Margin (2014 - 2026)
NovoCure recorded quarterly Gross Margin of 77.63% in Q1 2026, up 2.39% quarter-over-quarter from 75.82% in Q4 2025, and up 249.0% year-over-year from 22.24% in Q1 2025.
NovoCure's Gross Margin history runs 13 years deep, the most recent figure standing at 77.63% for Q1 2026.
- In Q1 2026, Gross Margin rose 249.0% year-over-year to 77.63%; the TTM figure through Mar 2026 stood at 75.2% (down 196.0% YoY), while the FY2025 annual figure was 74.54%, down 280.0% from the prior year.
- Gross Margin came in at 77.63% for Q1 2026 at NovoCure, up from 75.82% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 79.84% in Q1 2022 to a low of 73.01% in Q2 2023.
- A 5-year average of 76.38% and a median of 75.82% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 675 bps in 2023 and jumped 394 bps in 2024, its largest moves.
- NovoCure's Gross Margin stood at 77.51% in 2022, then decreased by 2 bps to 75.67% in 2023, then rose by 5 bps to 79.25% in 2024, then dropped by 4 bps to 75.82% in 2025, then climbed by 2 bps to 77.63% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 77.63%, 75.82%, and 73.25% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 77.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.63% |
| Dec 31, 2025 | 75.82% |
| Sep 30, 2025 | 73.25% |
| Jun 30, 2025 | 73.88% |
| Mar 31, 2025 | 75.15% |
| Dec 31, 2024 | 79.25% |
| Sep 30, 2024 | 77.19% |
| Jun 30, 2024 | 76.95% |
| Mar 31, 2024 | 75.68% |
| Dec 31, 2023 | 75.67% |
| Sep 30, 2023 | 74.79% |
| Jun 30, 2023 | 73.01% |
| Mar 31, 2023 | 75.76% |
| Dec 31, 2022 | 77.51% |
| Sep 30, 2022 | 77.29% |
| Jun 30, 2022 | 79.77% |
| Mar 31, 2022 | 79.84% |
| Dec 31, 2021 | 77.71% |
| Sep 30, 2021 | 77.39% |
| Jun 30, 2021 | 78.58% |
| Mar 31, 2021 | 80.41% |
| Dec 31, 2020 | 80.45% |
| Sep 30, 2020 | 78.60% |
| Jun 30, 2020 | 78.03% |
| Mar 31, 2020 | 75.94% |
| Dec 31, 2019 | 75.02% |
| Sep 30, 2019 | 75.13% |
| Jun 30, 2019 | 75.66% |
| Mar 31, 2019 | 72.97% |
| Dec 31, 2018 | 66.95% |
| Sep 30, 2018 | 70.74% |
| Jun 30, 2018 | 67.76% |
| Mar 31, 2018 | 65.01% |
| Dec 31, 2017 | 70.85% |
| Sep 30, 2017 | 69.76% |
| Jun 30, 2017 | 65.73% |
| Mar 31, 2017 | 66.56% |
| Dec 31, 2016 | 63.71% |
| Sep 30, 2016 | 48.70% |
| Jun 30, 2016 | 9.54% |
| Mar 31, 2016 | 38.85% |
| Dec 31, 2015 | 49.09% |
| Sep 30, 2015 | 36.79% |
| Jun 30, 2015 | 27.40% |
| Mar 31, 2015 | 25.17% |
| Dec 31, 2014 | 30.81% |
| Sep 30, 2014 | 40.88% |